Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3154-3158

  Wistuba, Ignacio I ^a,d   Montellano, Franklin D ^b   Milchgrub, Sara ^b   Virmani, Arvind K ^a,b   Bohrens, Carmen ^a   Chen, Hailei ^a   Ahmadian, Mohsen ^a   Nowak, Jan A ^c   Muller, Carolyn ^b   Minna, John D ^a,b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CHROMOSOME 13Q; CHROMOSOME 3P; CHROMOSOME 9P; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ACID ANHYDRIDE HYDROLASES; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; DNA, VIRAL; FEMALE; GENES, P53; GENES, RETINOBLASTOMA; HETEROZYGOTE; HUMANS; MICROSATELLITE REPEATS; MUTATION; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PROTEINS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 16944366174     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kurman, R. J. Blaustein's Pathology of the Female Genital Tract, pp. 229-326. New York: Springer-Verlag, 1994.
2. zur Hausen, H. Human papillomavirus in the pathogenesis of anogenital cancer. Virology, 184: 9-13, 1991.
3. Jones, M. H., Koi, S., Fujimoto, I., Hasumi, K., Kato, K., and Nakamura, Y. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arras 3p, 9q. 10q. and 17p. Genes Chromosomes Cancer, 9: 119-123, 1994.
4. Karlsen, F., Rabbitts, P. H., Sundresan, V., and Hagmar, B. PCR-RFLP studies on chromosome 3p in formaldehyde-fixed, paraffin-embedded cervical cancer tissues. Int. J. Cancer, 58: 787-792, 1994.
5. Kohno, T., Takayama, H., Hamaguchi, M., Takano, H., Yamaguchi, N., Tsuda, H., Hirohashi, S., Vissing, H., Shimizu, M., Oshimura, M., and Yokota, J. Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene, 8: 1825-32, 1993.
6. Mitra, A. B., Murty, V. V., Li, R. G., Pratap, M., Luthra, U. K., and Chaganti, R. S. Allelotype analysis of cervical carcinoma. J. Natl. Cancer Inst., 86: 850-855, 1994.
7. Rader, J. S., Kamarasova, T., Huettener, P. C., Li, L., Li, Y., and Gerhard, D. S. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene, 13: 2737-2741, 1997.
8. Minna, J. D., Sekido, Y., Fong, K., and Gazdar, A. F. Molecular biology of lung cancer. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Molecular Biology of Lung Cancer, pp. 849-857. Philadelphia: Lippincott, 1997.
9. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
10. Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I., and Glover, T. W. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Mol. Genet., 5: 187-195, 1996.
11. Fishel, R. Genomic instability, mutators, and the development of cancer: is there a role for p53? J. Natl. Cancer Inst., 88: 1608-1609, 1996.
12. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 558-563, 1995.
13. Cawkwell, L., Lewis, F. A., and Quirke, P. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br. J. Cancer, 70: 813-818, 1994.
14. Toguchida, J., McGee, T. L., Paterson, J. C., Eagle, J. R., Tucker, S., Yandell, D. W., and Dryja, T. P. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics, 17: 535-543, 1993.
15. Jones, M. H., Yamakawa, K., and Nakamura, Y. Isolation and characterization of 19 dinucleotide repeat polymorphisms on chromosome 3p. Hum. Mol. Genet., 1: 131-133, 1992.
16. Thiberville, L., Bourguignon, J., Metayer, J., Bost, F., Diarra-Mehrpour, M., Bignon, J., Lam, S., Martin, J. P., and Nouvel, G. Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small-cell lung cancer. Int. J. Cancer, 64: 371-377, 1995.
17. Kishimoto, Y., Sugio, K., Hung, J. Y., Virmani, A. K., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J. Natl. Cancer Inst., 87: 1224-1229, 1995.
18. Baay, M. F., Quint, W. G., Kuodstaal, J., Hollema, H., Duk, J. M., Burger, M. P., Stolz, E., and Herbrink, P. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. Clin. Microbiol., 1996.
19. Mitsudomi, T., Steinberg, S. M., Nau, M. M., Carbone, D., D'Amico, D., Bodner, S., Oie, H. K., Linnoila, R. I., Mulshine, J. L., Minna, J. D., and Gazdar, A. F. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7: 171-180, 1992.
20. Cullen, A. P., Reid, R., Campion, M., and Lorincz, A. T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasms. J. Virol., 65: 606-612, 1991.
21. Cannizzaro, L. A., Durst, M., Mendez, M. J., Hecht, B. K., and Hecht, F. Regional chromosome location of human papillomavirus integration sites near fragile sites, oncogenes and cancer chromosome breakpoints. Cancer Genet. Cytogenet., 33: 93-98, 1988.
22. Durst, M., Croce, C. M., Gissmann, L., Schwarz, E., and Huebner, K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA, 84: 1070-1074, 1987.
23. Pao, C. C., Kao, S. M., Chen, J. H., Tang, G. C., Chang, P. Y., and Tan, T. T. State of mutational alterations of p53 and retinoblastoma susceptibility genes in papillomavirus-negative small cell cervical carcinomas. Am. J. Clin. Pathol., 102: 665-670, 1994.
24. Paquette, R. L., Lee, Y. Y., Wilczynski, S. P., Karmakar, A., Kizaki, M., Miller, C. W., and Koeffler, H. P. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Anticancer Res., 13: 1107-1111, 1993.
25. Okamoto, A., Demetrick, D. J., Spillare, E. A., Hagiwara, K., Hussain, S. P., Bennett, W. P., Forrester, K., Gerwin, B., Serrano, M., Beach, D. H., and Harris, C. Mutations and altered expression of p16INK4 in human cancers. Proc. Natl. Acad. Sci. USA, 91: 11045-11049, 1994.
26. Mao, L., Lee, D., Tockman, M., Erozan, Y., Askin, F., and Sidransky, D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl. Acad. Sci. USA, 1994: 9871-9875, 1994.